¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21
±³À°ÀÏÀÚ : 2022-08-21
±³À°Àå¼Ò : ¿ë»ê ¹é¹ü±è±¸±â³ä°ü  
±³À°ÁÖÁ¦ : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ)
ÁÖÃÖ±â°ü : ´ëÇѺÎÀÎÁ¾¾çÇÐȸ
´ã´çÀÚ : ÁöÀºÁ¤
¿¬¶ôó : 02-512-5915  
À̸ÞÀÏ : gyncancer@gyncancer.or.kr      
±³À°Á¾·ù : »êºÎÀΰú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 10ºÐ  
¼¼ºÎ¼ö°­·á : 50,000¿ø      
ºñ°í Àü¹®ÀÇ 5¸¸¿ø, Àü°øÀÇ/°£È£»ç/¿¬±¸¿ø 3¸¸¿ø, ¿¬ÀÚ/ÁÂÀå/¸¸65¼¼ÀÌ»ó ¹«·á      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 09:40~09:55 Efficacy of single-dose HPV vaccination  ¿À¿µÅÃ(°­¿øÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 09:55~10:00 Discussion  À̽ÅÈ­(¿ï»êÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:00~10:15 Prognostic analysis of splenic parenchymal metastasis in advanced ovarian cancer: Does parenchymal metastasis matter?  ±èÁö¿¬(¾ÆÁÖÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:15~10:30 Clinical association of red blood cell distribution as prognostic marker in endometrial carcinoma  ÀÌÅ°æ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:30~10:45 Optimal cytoreduction and platinum-free interval affecting the duration of bevacizumab-based maintenance therapy and prognosis in the first platinum-sensitive recurrence of ovarian cancer  ¿À¼öÇö(°¡ÃµÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 10:45~11:00 Survival of incidentally found gynecologic cancer patients: multi-center retrospective study  À̼öÁ¤(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:00~11:15 Comparison of minimally invasive versus open surgery in treatment of endometrial cancer with high risk of recurrence  ÀåÁö¼±(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:15~11:30 Clinical implications of ovarian tumor size at diagnosis in patients with mucinous ovarian cancer  ÀÓÇöÁö(¼­¿ïÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 11:30~11:40 Distillation  ÀÌ»êÈñ¹Ú¼ºÅÃ(¿¬¼¼¿øÁÖÀÇ´ëÇѸ²ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 11:40~12:00 Abdominal and pelvic anatomy for gynecologic oncology surgery  À±º¸¼º(Â÷ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:00~12:20 Radiologic evaluation for resectability of gynecologic cancer: surgeon¡¯s perspective  À̼ºÁ¾(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:20~12:40 The role of lymphadenectomy in the management of gynecologic cancer  ½É½ÂÇõ(°Ç±¹ÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 12:40~12:50 Discussion  ±èÁ¤½Ä(¼øõÇâÀÇ´ëÇѾçÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 12:50~13:10 My experience of dV cervical cancer  ÃÖöÈÆ(¼º±Õ°üÀÇ´ë) 
½Ä»ç 08-21 ÄÁº¥¼ÇȦ 13:10~14:00 Lunch  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:00~14:20 How to easily perform pelvic lymph node dissection: basic anatomy and spaces  ³²ÀºÁö(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:20~14:40 Type of radical hysterectomies: from piver-rutledge-smith to present day  ¹Î°æÁø(°í·ÁÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 14:40~15:00 Principles and application of surgical staplers and vessel sealers  À̹æÇö(ÀÎÇÏÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 15:00~15:10 Discussion  ÀÌö¹Î(Â÷ÀÇ´ë±¹¸³¾Ï¼¾ÅÍ) 
È޽Ġ08-21 ÄÁº¥¼ÇȦ 15:10~15:40 Coffee break  () 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 15:40~16:00 Liver mobilization for full evaluation and resection of diaphragm  ¼­µ¿ÈÆ(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:00~16:20 Surgical approach for resection of pelvic sidewall tumors  ±èÈñ½Â(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:20~16:40 Splenectomy & distal pancreatectomy: surgical techique and postoperative care  ÀÓ°¡¿ø(µ¿±¹ÀÇ´ë) 
±³À°½Ã°£ 08-21 ÄÁº¥¼ÇȦ 16:40~17:00 Shall we do our bowel surgery? (gynecologic oncologist perspective)  ÀÌÀ¯¿µ(¼º±Õ°üÀÇ´ë) 
Åä·Ð 08-21 ÄÁº¥¼ÇȦ 17:00~17:10 Discussion  ±èÀ±È¯ÃÖÇöÁø(ÀÌÈ­ÀÇ´ëÁß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇѺÎÀÎÁ¾¾çÇÐȸ ÇÏ°èÇмú´ëȸ(Á¦16Â÷ ÀþÀºÀÇ»ç¿öÅ©¼¥ & Á¦5Â÷ ºÐ°úÀü¹®ÀÇ¿¬¼ö°­ÁÂ) : 2022-08-21""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û Á¦8ȸ ´ëÇѽŰæ¿Ü°ú º´¿øÇùÀÇȸ Çмú´ëȸ : 2022-08-21
´ÙÀ½±Û (¿Â¶óÀÎ) ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ 2022³âµµ ÀÓ»ó³úÆÄ ÇÏ°è ¿öÅ©¼ó : 2022-08-20
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20893 ¼­¿ï ´ëÇѳúÁ¹ÁßÇÐȸ 6¿ù º¸¼ö±³À° : 2024-06-30 0 121 2024-05-27
20892 ¼­¿ï (¿Â¶óÀÎ)Á¦22Â÷ ¼­¿ïƯº°½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-30 0 42 2024-05-27
20891 °æ±â (¿Â¶óÀÎ)Á¦21Â÷ °æ±âµµÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-30 0 121 2024-05-27
20890 Àü³² 2024³â ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ ¿¬¼ö°­Á : 2024-06-30 0 34 2024-05-27
20889 Ãæ³² ´ëÇÑÁ¤Çü¿Ü°úÃÊÀ½ÆÄÇÐȸ - Á¦19Â÷ Ãá°èÇмú´ëȸ ¹× Á¦38Â÷ ±Ù°ñ°Ý°è ÃÊÀ½ÆÄ¿öÅ©¼¥ (Basic Course) : 2024-06-30 0 23 2024-05-27
20888 ºÎ»ê Á¦3ȸ ´ëÇÑÅõ¼®Çùȸ ºÎ»êÁöȸ ½ÉÆ÷Áö¾ö : 2024-06-29 0 25 2024-05-27
20887 ¼­¿ï Çѱ¹ÁöÁú¤ýµ¿¸Æ°æÈ­ÇÐȸ Á¦7ȸ A to Z (Atherosclerosis to Zero) ¿¬¼ö°­Á ÇÁ·Î±×·¥ : 2024-06-29 0 44 2024-05-27
20886 °æ±â 2024³âµµ ³²¾çÁÖ½ÃÀÇ»çȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
20885 ¼­¿ï (¿Â¶óÀÎ)Á¦14ȸ ´ëÇÑ°¨¿°ÇÐȸ Æò»ý±³À° ÇÁ·Î±×·¥ °¨¿°Áúȯ ÃÖ½ÅÁö°ß : 2024-06-29 0 21 2024-05-27
20884 ¼­¿ï Á¦24Â÷ ´ëÇѽÅÀåÇÐȸ ½ÅÀ̽Ŀ¬±¸È¸ ¿¬¼ö°­Á : 2024-06-29 0 12 2024-05-27
20883 ¼­¿ï 2024 ¼±Ãµ¼º Ⱦ°æ¸· Å»Àå ÄÚȣƮ (K-CDH) ±³À°¼¼¹Ì³ª : 2024-06-29 0 18 2024-05-27
20882 ¼­¿ï 2024 ¿©¼º½ÉÀåÁúȯ¿¬±¸È¸ ÇÏ°è ½ÉÆ÷Áö¾ö : 2024-06-29 0 22 2024-05-27
20881 °­¿ø 2024 ³âµµ Á¤Çü¿Ü°úÇб³½Ç °³¿øÀÇ¿¬¼ö°­Á : 2024-06-29 0 21 2024-05-27
20880 ¼­¿ï (¿Â¶óÀÎ) 2024 ¸¶Æ÷±¸ÀÇ»çȸ ¿Â¶óÀÎ Çмú´ëȸ : 2024-06-29 0 20 2024-05-27
20879 ¼­¿ï Á¦10ȸ ¿ëºÀÀÇÇÐȸ Çмú´ëȸ : 2024-06-29 0 13 2024-05-27
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷